• Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Newsroom
    • Careers
CONTACT US

SIGN IN

  • Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Newsroom
    • Careers
How does approval of a new Alzheimer’s drug impact genetic testing?

How does approval of a new Alzheimer’s drug impact genetic testing?

by Truveta Research | Apr 21, 2023 | Research, Research Insights

The National Institute of Health estimates that more than six million Americans over the age of 65 suffer from Alzheimer’s disease, with many more under the age of 65 also having the disease (National Institute on Aging, 2021). It is currently ranked as the seventh...

Recent Posts

  • Ozempic, Wegovy, and Mounjaro: On- and off-label prescribing trends
  • A pragmatic suggestion for medical AI regulation
  • Unlocking Insights: Stroke Research with Truveta
  • Truveta Spotlight: Dr. Marty Doerfler, EVP of Healthcare
  • Q&A: Exploring with The Wall Street Journal Truveta’s EHR data on speech delays

Categories

  • Culture
  • News
  • Research
  • Research Insights
  • Technology

Archive

  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • March 2021
  • February 2021
  • December 2020
  • October 2020

Ready to join us on our mission of Saving Lives with Data?

Get started
  • Follow
  • Follow

Truveta Data

Truveta Studio

Research

Resources

Blog

Leadership

Governance

Newsroom

Careers

Contact us

Privacy Notice

© Truveta 2023

Interested in learning more?

Reach out and we’ll schedule a demo.